Bend Research, Inc.

64550 RESEARCH RD
Bend, OR 97701
http://www.bendresearch.com/
130 Employees

SBIR Award Summary

Total Number of Awards 166
Total Value of Awards $21.8MM
First Award Date 01/01/83
Most Recent Award Date 09/01/00

166 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/00 - 11/30/01

The goal of this program is to develop hollow-fiber membranes and fiber fabrics that are customized for use in the Intravenous Membrane Oxygenator (IMO) under development at the University of Pittsburgh. The IMO is being developed as a method of augmenting incomplete respiration in adults with acute respiratory failure. Although the current vers...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/00 - 08/31/02

This goal of this program is to develop a new process for rapidly generating mixtures of derivatives (i.e., derivative libraries) with chemical structures that are based on the structure of a single bioactive parent compound. The proposed process makes it possible to produce structurally distinct derivatives rapidly and to produce derivatives n...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/99 - 08/31/00

This goal of this program is to develop a new process for rapidly generating mixtures of derivatives (i.e., derivative libraries) with chemical structures that are based on the structure of a single bioactive parent compound. The proposed process makes it possible to produce structurally distinct derivatives rapidly and to produce derivatives n...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/01/99 - 01/31/02

Intravascular membrane oxygenators represent a promising therapy for Acute Respiratory Distress Syndrome (ARDS), a medical condition that has a mortality rate of 50% due to hypoxemic respiratory failure. Intra- vascular oxygenators avoid the barotrauma and volutrauma associated with mechanical ventilation ...

Phase 1 SBIR

Agency: National Science Foundation
Topic: 1999
Budget: 01/01/99 - 12/31/99

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/98 - 08/31/99

DESCRIPTION: The proposed Phase I project is aimed at developing a new process for generating mixtures of compounds with unique structures. As envisioned, these mixtures of novel compounds (termed "chemical libraries") will have attributes appropriate for subjecting them to high-throughput screen...

Phase 2 STTR

Institution: University of Oregon

Agency: Defense Advanced Research Projects Agency
Topic: ST97-002
Budget: 06/26/98 - 10/30/00

The goal of this Phase II project is to develop a new class of optical - recording materials that will be enabling for a variety of DARPA applications, including analog optical recording, optical data storage, optical correlators, and optical interconnects. These materials could be used as high-capacity, fast-access-time, analog holographic opt...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/98 - 11/30/98

DESCRIPTION (Adapted from Applicant's Abstract): The goal of this program is to develop a new technology for generating biologically active libraries of compounds for high-throughput screening in drug discovery. This new synthesis method will make it possible to create large numbers of drug-c...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/98 - 02/29/00

DESCRIPTION (Adapted from the application): Vaccines typically involve and initial dose of antigen, followed by a booster dose at some later time. The need for administration of a booster dose clearly limits the practicality of vaccines in much of the world. The objective of the proposed program is to ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/01/98 - 01/31/99

Intravascular membrane oxygenators represent a promising therapy for Acute Respiratory Distress Syndrome (ARDS), a medical condition that has a mortality rate of 50% due to hypoxemic respiratory failure. Intra- vascular oxygenators avoid the barotrauma and volutrauma associated with mechanical ventilation ...

Load More